News
Dealbreaker on MSN42m
BioNTech to Pay $740M-Plus to Settle mRNA Patent Disputes, Smooth $1.25 Billion Deal
In litigation over the past two years, CureVac alleged the BioNTech and Pfizer vaccine for Covid-19 infringed CureVac patents ...
As momentum builds toward the highly anticipated GDAI 2025, DataGlobal Hub is proud to unveil what participants should expect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback